top of page

Who will benefit from the more accurate measurement of RBC deformability and CSS?

Ultimately, anyone at risk of developing circulatory disorders will benefit from better technology for measuring cell deformability and critical shear stress. Quick and easy measurements at the point of care will provide earlier detection of the circulatory diseases including diabetic kidney disease and diabetic retinopathy , allowing patients to be treated on time and to have healthy life.

14 views0 comments

Recent Posts

See All

RheoScan received approval from Korea Food & Drug Administration(KFDA) though GMP tests as a First class medical device in Dec., 2005. Furthermore, RheoScan have declared CE for high quality manufactu

bottom of page